Industry: Consumer Goods
Published Date: 2025-09-11
Pages: 172 Pages
Report ld: 5044459
Request Sample
Customized Report
The global Intraocular Lens (IOLs) market is projected to grow from US$ million in 2024 to US$ million by 2031, at a CAGR of %(2025-2031), driven by critical product segments and diverse end‑use applications, while evolving U.S. tariff policies introduce trade‑cost volatility and supply‑chain uncertainty.
Intraocular lens (IOL) is a lens implanted in the eye used to treat cataracts or myopia. The most common type of IOL is the pseudophakic IOL. These are implanted during cataract surgery, after the cloudy crystalline lens (otherwise known as a cataract) has been removed. The pseudophakic IOL replaces the original crystalline lens, and provides the light focusing function originally undertaken by the crystalline lens. The second type of IOL, more commonly known as a phakic intraocular lens (PIOL), is a lens which is placed over the existing natural lens, and is used in refractive surgery to change the eye"s optical power as a treatment for myopia, or nearsightedness. IOL usually consist of a small plastic lens with plastic side struts, called haptics, to hold the lens in place within the capsular bag inside the eye. IOL were conventionally made of an inflexible material (PMMA), although this has largely been superseded by the use of flexible materials. Most IOL fitted today are fixed monofocal lenses matched to distance vision. However, other types are available, such as multifocal IOL which provide the patient with multiple-focused vision at far and reading distance, and adaptive IOL which provide the patient with limited visual accommodation.
In the Europe market, Alcon profits most and recent years, while Bausch & Lomb and AMO (J&J) ranked 2 and 3.The market share of them is 19%, 10% and 9%.
Report Includes:
This definitive report equips CEOs, marketing directors, and investors with a 360° view of the global Intraocular Lens (IOLs) market, seamlessly integrating production and sales performance across the value chain. It analyzes historical sales volume and revenue sales data (2020–2024) and delivers forecasts through 2031, illuminating demand trends and growth drivers.
By segmenting the market by Type and by Application, the study quantifies volume and value, growth rates, technical innovations, niche opportunities, and substitution risks, and analyzes downstream customers distribution pattern.
Granular regional insights cover five major markets—North America, Europe, APAC, South America, and MEA—with in‑depth analysis of 20+ countries. Each region’s dominant products, competitive landscape, and downstream demand trends are clearly detailed.
Critical competitive intelligence profiles manufacturers—sales volume, revenue, margins, pricing strategies, and major customers—and dissects the top-player positioning across product lines, applications, and regions to reveal strategic strengths.
A concise supply‑chain overview maps upstream suppliers, manufacturing technologies, cost structures, and distribution dynamics to identify strategic gaps and unmet demand.
MARKET SEGMENTATION
CHAPTER OUTLINE
Chapter 1: Defines the Intraocular Lens (IOLs) study scope, segments the market by Type and by Application, etc, highlights segment size and growth potential.
Chapter 2: Offers current market state, projects global revenue and sales to 2031, pinpointing high consumption regions and emerging market catalysts
Chapter 3: Dissects the manufacturer landscape—ranks by volume and revenue, analyzes profitability and pricing, maps production bases, details manufacturer performance by product type and evaluates concentration alongside M&A moves.
Chapter 4: Unlocks high margin product segments—compares sales, revenue, ASP, and technology differentiators, highlighting growth niches and substitution risks
Chapter 5: Targets downstream market opportunities—evaluates sales, revenue, and pricing by Application, identifies emerging use cases, and profiles leading customers by region and by Application.
Chapter 6: North America—breaks down sales and revenue by Type, by Application and country, profiles key manufacturers and assesses growth drivers and barriers.
Chapter 7: Europe—analyses regional sales, revenue and market by Type, by Application and manufacturers, flagging drivers and barriers.
Chapter 8: Asia Pacific—quantifies sales and revenue by Type, by Application, and region/country, profiles top manufacturers, and uncovers high potential expansion areas.
Chapter 9: Central & South America—measures sales and revenue by Type, by Application, and country, profiles top manufacturers, and identifies investment opportunities and challenges.
Chapter 10: Middle East and Africa—evaluates sales and revenue by Type, by Application, and country, profiles key manufacturers, and outlines investment prospects and market hurdles
Chapter 11: Profiles manufacturers in depth—details product specs, sales, revenue, margins; Top manufactures 2024 sales breakdowns by Product type, by Application, by sales region SWOT analysis, and recent strategic developments.
Chapter 12: Supply chain—analyses upstream raw materials and suppliers, manufacturing footprint, regional production and cost, regulatory and technology, plus downstream channels and distributor roles.
Chapter 13: Market dynamics—explores drivers, restraints, regulatory impacts, and risk mitigation strategies.
Chapter 15: Actionable conclusions and strategic recommendations.
WHY THIS REPORT
Beyond standard market data, this analysis provides a clear profitability roadmap, empowering you to:
Beyond standard market data, this analysis provides a clear profitability roadmap—empowering you to:
Allocate capital strategically to high growth regions (Chapters 6–10) and margin rich segments (Chapter 5).
Negotiate from strength with suppliers (Chapter 12) and customers (Chapter5) using cost and demand intelligence.
Outmaneuver competitors with granular insights into their operations, margins, and strategies (Chapters 3 and 11).
Secure your supply chain against disruptions through upstream and downstream visibility (Chapters 12 and 13).
Leverage this 360° intelligence to turn market complexity into actionable competitive advantage.
QYRESEARCH'S STRENGTHS
Unlike generic global market reports, this study combines macro-level industry trends with hyper-local operational intelligence, empowering data-driven decisions across the Compound Chocolate value chain, addressing:
We identify regional market threats and growth prospects to guide your overseas layout.
We adjust product portfolios in line with local consumption habits.
We unpack rivals’ operation strategies for scattered and highly concentrated industries.
We cover competition landscape, full supply chain and quantified market size data, and deliver tailor-made customized surveys to meet your unique business demands.
We own self-owned massive exclusive databases, backed by 19 years of global market research experience across thousands of sectors.
Our team operates 24 hours a day, 365 days a year, enabling ultra-fast report turnaround to respond to your research needs efficiently.
We integrate regional risk assessment, localized product optimization and competitor analysis to deliver actionable market strategies.
All data is cross-verified from multiple industry sources to deliver thorough, precise analysis that supports reliable corporate strategic decisions.
We provide responsive, dedicated after-sales support to resolve all follow-up inquiries about reports, data and industry interpretation.
TABLE OF CONTENTS
1 Study Coverage
1.1 Introduction to Intraocular Lens (IOLs): Definition, Properties, and Key Attributes
1.2 Market Segmentation by Type
1.2.1 Global Intraocular Lens (IOLs) Market Size by Type, 2020 VS 2024 VS 2031
1.2.2 Non-Foldable Lenses
1.2.3 Foldable Intraocular Lens
1.3 Market Segmentation by Application
1.3.1 Global Intraocular Lens (IOLs) Market Size by Application, 2020 VS 2024 VS 2031
1.3.2 Hydrophilic
1.3.3 Hydrophobic
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Executive Summary
2.1 Global Intraocular Lens (IOLs) Revenue Estimates and Forecasts 2020-2031
2.2 Global Intraocular Lens (IOLs) Revenue by Region
2.2.1 Revenue Comparison: 2020 VS 2024 VS 2031
2.2.2 Historical and Forecasted Revenue by Region (2020--2031)
2.2.3 Global Revenue Market Share by Region (2020-2031)
2.3 Global Intraocular Lens (IOLs) Sales Estimates and Forecasts 2020-2031
2.4 Global Intraocular Lens (IOLs) Sales by Region
2.4.1 Sales Comparison: 2020 VS 2024 VS 2031
2.4.2 Historical and Forecasted Sales by Region (2020-2031)
2.4.3 Emerging Market Focus: Growth Drivers & Investment Trends
2.4.4 Global Sales Market Share by Region (2020-2031)
3 Competition by Manufacturers
3.1 Global Intraocular Lens (IOLs) Sales by Manufacturers
3.1.1 Global Sales Volume by Manufacturers (2020-2025)
3.1.2 Global Top 5 and Top 10 Manufacturers’Market Share by Sales Volume (2024)
3.2 Global Intraocular Lens (IOLs) Manufacturer Revenue Rankings and Tiers
3.2.1 Global Revenue (Value) by Manufacturers (2020-2025)
3.2.2 Global Key Manufacturer Revenue Ranking (2023 vs. 2024)
3.2.3 Revenue-Based Tier Segmentation (Tier 1, Tier 2, and Tier 3)
3.3 Manufacturer Profitability Profiles and Pricing Strategies
3.3.1 Gross Margin by Top Manufacturer (2020 VS 2024)
3.3.2 Manufacturer-Level Price Trends (2020-2025)
3.4 Key Manufacturers Manufacturing Base and Headquarters
3.5 Main Product Type Market Size by Manufacturers
3.5.1 Non-Foldable Lenses Market Size by Manufacturers
3.5.2 Foldable Intraocular Lens Market Size by Manufacturers
3.6 Global Intraocular Lens (IOLs) Market Concentration and Dynamics
3.6.1 Global Market Concentration (CR5 and HHI)
3.6.2 Entrant/Exit Impact Analysis
3.6.3 Strategic Moves: M&A, Capacity Expansion, R&D Investment
4 Global Product Segmentation Analysis
4.1 Global Intraocular Lens (IOLs) Sales Performance by Type
4.1.1 Global Historical and Forecasted Sales by Type (2020-2031)
4.1.2 Global Sales Market Share by Type (2020-2031)
4.2 Global Intraocular Lens (IOLs) Revenue Trends by Type
4.2.1 Global Historical and Forecasted Revenue by Type (2020-2031)
4.2.2 Global Revenue Market Share by Type (2020-2031)
4.3 Global Average Selling Price (ASP) Trends by Type (2020-2031)
4.4 Product Technology Differentiation
4.5 Subtype Dynamics: Growth Leaders, Profitability and Risk
4.5.1 High-Growth Niches and Adoption Drivers
4.5.2 Profitability Hotspots and Cost Drivers
4.5.3 Substitution Threats
5 Global Downstream Application Analysis
5.1 Global Intraocular Lens (IOLs) Sales by Application
5.1.1 Global Historical and Forecasted Sales by Application (2020-2031)
5.1.2 Global Sales Market Share by Application (2020-2031)
5.1.3 High-Growth Application Identification
5.1.4 Emerging Application Case Studies
5.2 Global Intraocular Lens (IOLs) Revenue by Application
5.2.1 Global Historical and Forecasted Revenue by Application (2020-2031)
5.2.2 Revenue Market Share by Application (2020-2031)
5.3 Global Pricing Dynamics by Application (2020-2031)
5.4 Downstream Customer Analysis
5.4.1 Top Customers by Region
5.4.2 Top Customers by Application
6 North America
6.1 North America Sales Volume and Revenue (2020-2031)
6.2 North America Key Manufacturers Sales Revenue in 2024
6.3 North America Intraocular Lens (IOLs) Sales and Revenue by Type (2020-2031)
6.4 North America Intraocular Lens (IOLs) Sales and Revenue by Application (2020-2031)
6.5 North America Growth Accelerators and Market Barriers
6.6 North America Intraocular Lens (IOLs) Market Size by Country
6.6.1 North America Revenue by Country
6.6.2 North America Sales Trends by Country
6.6.3 US
6.6.4 Canada
6.6.5 Mexico
7 Europe
7.1 Europe Sales Volume and Revenue (2020-2031)
7.2 Europe Key Manufacturers Sales Revenue in 2024
7.3 Europe Intraocular Lens (IOLs) Sales and Revenue by Type (2020-2031)
7.4 Europe Intraocular Lens (IOLs) Sales and Revenue by Application (2020-2031)
7.5 Europe Growth Accelerators and Market Barriers
7.6 Europe Intraocular Lens (IOLs) Market Size by Country
7.6.1 Europe Revenue by Country
7.6.2 Europe Sales Trends by Country
7.6.3 Germany
7.6.4 France
7.6.5 U.K.
7.6.6 Italy
7.6.7 Russia
8 Asia-Pacific
8.1 Asia-Pacific Sales Volume and Revenue (2020-2031)
8.2 Asia-Pacific Key Manufacturers Sales Revenue in 2024
8.3 Asia-Pacific Intraocular Lens (IOLs) Sales and Revenue by Type (2020-2031)
8.4 Asia-Pacific Intraocular Lens (IOLs) Sales and Revenue by Application (2020-2031)
8.5 Asia-Pacific Intraocular Lens (IOLs) Market Size by Region
8.5.1 Asia-Pacific Revenue by Region
8.5.2 Asia-Pacific Sales Trends by Region
8.6 Asia-Pacific Growth Accelerators and Market Barriers
8.7 Southeast Asia
8.7.1 Southeast Asia Revenue by Country (2020 VS 2024 VS 2031)
8.7.2 Key Country Analysis: Indonesia, Vietnam, Thailand, Malaysia, Philippines
8.8 China
8.9 Japan
8.10 South Korea
8.11 China Taiwan
8.12 India
9 Central and South America
9.1 Central and South America Sales Volume and Revenue (2020-2031)
9.2 Central and South America Key Manufacturers Sales Revenue in 2024
9.3 Central and South America Intraocular Lens (IOLs) Sales and Revenue by Type (2020-2031)
9.4 Central and South America Intraocular Lens (IOLs) Sales and Revenue by Application (2020-2031)
9.5 Central and South America Investment Opportunities and Key Challenges
9.6 Central and South America Intraocular Lens (IOLs) Market Size by Country
9.6.1 Central and South America Revenue Trends by Country (2020 VS 2024 VS 2031)
9.6.2 Brazil
9.6.3 Argentina
10 Middle East and Africa
10.1 Middle East and Africa Sales Volume and Revenue (2020-2031)
10.2 Middle East and Africa Key Manufacturers Sales Revenue in 2024
10.3 Middle East and Africa Intraocular Lens (IOLs) Sales and Revenue by Type (2020-2031)
10.4 Middle East and Africa Intraocular Lens (IOLs) Sales and Revenue by Application (2020-2031)
10.5 Middle East and Africa Investment Opportunities and Key Challenges
10.6 Middle East and Africa Intraocular Lens (IOLs) Market Size by Country
10.6.1 Middle East and Africa Revenue Trends by Country (2020 VS 2024 VS 2031)
10.6.2 GCC Countries
10.6.3 Turkey
10.6.4 Egypt
10.6.5 South Africa
11 Corporate Profile
11.1 Alcon
11.1.1 Alcon Corporation Information
11.1.2 Alcon Business Overview
11.1.3 Alcon Intraocular Lens (IOLs) Product Models, Descriptions and Specifications
11.1.4 Alcon Intraocular Lens (IOLs) Sales, Price, Revenue and Gross Margin (2020-2025)
11.1.5 Alcon Intraocular Lens (IOLs) Sales by Product in 2024
11.1.6 Alcon Intraocular Lens (IOLs) Sales by Application in 2024
11.1.7 Alcon Intraocular Lens (IOLs) Sales by Geographic Area in 2024
11.1.8 Alcon Intraocular Lens (IOLs) SWOT Analysis
11.1.9 Alcon Recent Developments
11.2 Rayner
11.2.1 Rayner Corporation Information
11.2.2 Rayner Business Overview
11.2.3 Rayner Intraocular Lens (IOLs) Product Models, Descriptions and Specifications
11.2.4 Rayner Intraocular Lens (IOLs) Sales, Price, Revenue and Gross Margin (2020-2025)
11.2.5 Rayner Intraocular Lens (IOLs) Sales by Product in 2024
11.2.6 Rayner Intraocular Lens (IOLs) Sales by Application in 2024
11.2.7 Rayner Intraocular Lens (IOLs) Sales by Geographic Area in 2024
11.2.8 Rayner Intraocular Lens (IOLs) SWOT Analysis
11.2.9 Rayner Recent Developments
11.3 Bausch & Lomb
11.3.1 Bausch & Lomb Corporation Information
11.3.2 Bausch & Lomb Business Overview
11.3.3 Bausch & Lomb Intraocular Lens (IOLs) Product Models, Descriptions and Specifications
11.3.4 Bausch & Lomb Intraocular Lens (IOLs) Sales, Price, Revenue and Gross Margin (2020-2025)
11.3.5 Bausch & Lomb Intraocular Lens (IOLs) Sales by Product in 2024
11.3.6 Bausch & Lomb Intraocular Lens (IOLs) Sales by Application in 2024
11.3.7 Bausch & Lomb Intraocular Lens (IOLs) Sales by Geographic Area in 2024
11.3.8 Bausch & Lomb Intraocular Lens (IOLs) SWOT Analysis
11.3.9 Bausch & Lomb Recent Developments
11.4 AMO (J&J)
11.4.1 AMO (J&J) Corporation Information
11.4.2 AMO (J&J) Business Overview
11.4.3 AMO (J&J) Intraocular Lens (IOLs) Product Models, Descriptions and Specifications
11.4.4 AMO (J&J) Intraocular Lens (IOLs) Sales, Price, Revenue and Gross Margin (2020-2025)
11.4.5 AMO (J&J) Intraocular Lens (IOLs) Sales by Product in 2024
11.4.6 AMO (J&J) Intraocular Lens (IOLs) Sales by Application in 2024
11.4.7 AMO (J&J) Intraocular Lens (IOLs) Sales by Geographic Area in 2024
11.4.8 AMO (J&J) Intraocular Lens (IOLs) SWOT Analysis
11.4.9 AMO (J&J) Recent Developments
11.5 HOYA
11.5.1 HOYA Corporation Information
11.5.2 HOYA Business Overview
11.5.3 HOYA Intraocular Lens (IOLs) Product Models, Descriptions and Specifications
11.5.4 HOYA Intraocular Lens (IOLs) Sales, Price, Revenue and Gross Margin (2020-2025)
11.5.5 HOYA Intraocular Lens (IOLs) Sales by Product in 2024
11.5.6 HOYA Intraocular Lens (IOLs) Sales by Application in 2024
11.5.7 HOYA Intraocular Lens (IOLs) Sales by Geographic Area in 2024
11.5.8 HOYA Intraocular Lens (IOLs) SWOT Analysis
11.5.9 HOYA Recent Developments
11.6 Physiol
11.6.1 Physiol Corporation Information
11.6.2 Physiol Business Overview
11.6.3 Physiol Intraocular Lens (IOLs) Product Models, Descriptions and Specifications
11.6.4 Physiol Intraocular Lens (IOLs) Sales, Price, Revenue and Gross Margin (2020-2025)
11.6.5 Physiol Recent Developments
11.7 CARL Zeiss
11.7.1 CARL Zeiss Corporation Information
11.7.2 CARL Zeiss Business Overview
11.7.3 CARL Zeiss Intraocular Lens (IOLs) Product Models, Descriptions and Specifications
11.7.4 CARL Zeiss Intraocular Lens (IOLs) Sales, Price, Revenue and Gross Margin (2020-2025)
11.7.5 CARL Zeiss Recent Developments
11.8 MossVision
11.8.1 MossVision Corporation Information
11.8.2 MossVision Business Overview
11.8.3 MossVision Intraocular Lens (IOLs) Product Models, Descriptions and Specifications
11.8.4 MossVision Intraocular Lens (IOLs) Sales, Price, Revenue and Gross Margin (2020-2025)
11.8.5 MossVision Recent Developments
11.9 OPHTEC
11.9.1 OPHTEC Corporation Information
11.9.2 OPHTEC Business Overview
11.9.3 OPHTEC Intraocular Lens (IOLs) Product Models, Descriptions and Specifications
11.9.4 OPHTEC Intraocular Lens (IOLs) Sales, Price, Revenue and Gross Margin (2020-2025)
11.9.5 OPHTEC Recent Developments
11.10 VSY Biotechnology
11.10.1 VSY Biotechnology Corporation Information
11.10.2 VSY Biotechnology Business Overview
11.10.3 VSY Biotechnology Intraocular Lens (IOLs) Product Models, Descriptions and Specifications
11.10.4 VSY Biotechnology Intraocular Lens (IOLs) Sales, Price, Revenue and Gross Margin (2020-2025)
11.10.5 VSY Biotechnology Recent Developments
11.11 HumanOptics
11.11.1 HumanOptics Corporation Information
11.11.2 HumanOptics Business Overview
11.11.3 HumanOptics Intraocular Lens (IOLs) Product Models, Descriptions and Specifications
11.11.4 HumanOptics Intraocular Lens (IOLs) Sales, Price, Revenue and Gross Margin (2020-2025)
11.11.5 HumanOptics Recent Developments
11.12 Cristalens
11.12.1 Cristalens Corporation Information
11.12.2 Cristalens Business Overview
11.12.3 Cristalens Intraocular Lens (IOLs) Product Models, Descriptions and Specifications
11.12.4 Cristalens Intraocular Lens (IOLs) Sales, Price, Revenue and Gross Margin (2020-2025)
11.12.5 Cristalens Recent Developments
11.13 SAV-IOL
11.13.1 SAV-IOL Corporation Information
11.13.2 SAV-IOL Business Overview
11.13.3 SAV-IOL Intraocular Lens (IOLs) Product Models, Descriptions and Specifications
11.13.4 SAV-IOL Intraocular Lens (IOLs) Sales, Price, Revenue and Gross Margin (2020-2025)
11.13.5 SAV-IOL Recent Developments
11.14 STAAR Surgical
11.14.1 STAAR Surgical Corporation Information
11.14.2 STAAR Surgical Business Overview
11.14.3 STAAR Surgical Intraocular Lens (IOLs) Product Models, Descriptions and Specifications
11.14.4 STAAR Surgical Intraocular Lens (IOLs) Sales, Price, Revenue and Gross Margin (2020-2025)
11.14.5 STAAR Surgical Recent Developments
11.15 Medicontur
11.15.1 Medicontur Corporation Information
11.15.2 Medicontur Business Overview
11.15.3 Medicontur Intraocular Lens (IOLs) Product Models, Descriptions and Specifications
11.15.4 Medicontur Intraocular Lens (IOLs) Sales, Price, Revenue and Gross Margin (2020-2025)
11.15.5 Medicontur Recent Developments
11.16 InfiniteVision Optics
11.16.1 InfiniteVision Optics Corporation Information
11.16.2 InfiniteVision Optics Business Overview
11.16.3 InfiniteVision Optics Intraocular Lens (IOLs) Product Models, Descriptions and Specifications
11.16.4 InfiniteVision Optics Intraocular Lens (IOLs) Sales, Price, Revenue and Gross Margin (2020-2025)
11.16.5 InfiniteVision Optics Recent Developments
12 Value Chain and Supply-Chain Analysis
12.1 Intraocular Lens (IOLs) Industry Chain
12.2 Intraocular Lens (IOLs) Upstream Materials Analysis
12.2.1 Raw Materials
12.2.2 Key Suppliers Market Share & Risk Assessment
12.3 Intraocular Lens (IOLs) Integrated Production Analysis
12.3.1 Manufacturing Footprint Analysis
12.3.2 Regional Production Market Share (2020-2031)
12.3.3 Regulatory and Trade Policy Impact on Production
12.3.4 Production Technology Overview
12.3.5 Regional Cost Drivers
12.4 Intraocular Lens (IOLs) Sales Channels and Distribution Networks
12.4.1 Sales Channels
12.4.2 Distributors
13 Intraocular Lens (IOLs) Market Dynamics
13.1 Industry Trends and Evolution
13.2 Market Growth Drivers and Emerging Opportunities
13.3 Market Challenges, Risks, and Restraints
14 Key Findings in the Global Intraocular Lens (IOLs) Study
15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.1.1 Research Programs/Design
15.1.1.2 Market Size Estimation
15.1.1.3 Market Breakdown and Data Triangulation
15.1.2 Data Source
15.1.2.1 Secondary Sources
15.1.2.2 Primary Sources
15.2 Author Details
TABLE OF FIGURES
List of Tables
List of Figures
KEY QUESTIONS ADDRESSED BY THE REPORT
Related Reports
The global Intraocular Lens (IOLs) market size was US$ million in 2025 and is forecast to reach a readjusted size of US$ million by 2032 with a CAGR of %during the forecast period 2026-2032.
Published Date: 2026-01-04
Pages: 107
USD 4250.00
(Single User License)
The global Intraocular Lens (IOLs) market was valued at US$ million in 2025 and is anticipated to reach US$ million by 2032, at a CAGR of %from 2026 to 2032.
Published Date: 2026-01-04
Pages: 137
USD 2900.00
(Single User License)
The global market for Intraocular Lens (IOLs) was estimated to be worth US$ million in 2025 and is projected to reach US$ million, growing at a CAGR of %from 2026 to 2032.
Published Date: 2026-01-04
Pages: 143
USD 3950.00
(Single User License)
In 2024, the global market size of Intraocular Lens (IOLs) was estimated to be worth US$ million and is forecast to reach approximately US$ million by 2031 with a CAGR of %during the forecast period 2025-2031.
Published Date: 2025-03-28
Pages: 177
USD 5900.00
(Single User License)
The global Intraocular Lens (IOLs) market size was US$ million in 2024 and is forecast to a readjusted size of US$ million by 2031 with a CAGR of %during the forecast period 2025-2031.
Published Date: 2025-03-19
Pages: 110
USD 4250.00
(Single User License)
The global market for Intraocular Lens (IOLs) was estimated to be worth US$ million in 2024 and is forecast to a readjusted size of US$ million by 2031 with a CAGR of %during the forecast period 2025-2031.
Published Date: 2025-01-16
Pages: 146
USD 3950.00
(Single User License)
The global market for Intraocular Lens (IOLs) was valued at US$ million in the year 2024 and is projected to reach a revised size of US$ million by 2031, growing at a CAGR of %during the forecast period.
Published Date: 2025-01-16
Pages: 99
USD 2900.00
(Single User License)
Intraocular lens (IOL) is a lens implanted in the eye used to treat cataracts or myopia. The most common type of IOL is the pseudophakic IOL. These are implanted during cataract surgery, after the cloudy crystalline lens (otherwise known as a cataract) has been removed. The pseudophakic IOL replaces the original crystalline lens, and provides the light focusing function originally undertaken by the crystalline lens. The second type of IOL, more commonly known as a phakic intraocular lens (PIOL), is a lens which is placed over the existing natural lens, and is used in refractive surgery to change the eye's optical power as a treatment for myopia, or nearsightedness. IOL usually consist of a small plastic lens with plastic side struts, called haptics, to hold the lens in place within the capsular bag inside the eye. IOL were conventionally made of an inflexible material (PMMA), although this has largely been superseded by the use of flexible materials. Most IOL fitted today are fixed monofocal lenses matched to distance vision. However, other types are available, such as multifocal IOL which provide the patient with multiple-focused vision at far and reading distance, and adaptive IOL which provide the patient with limited visual accommodation.
Published Date: 2024-04-17
Pages: 185
USD 5600.00
(Single User License)
Intraocular lens (IOL) is a lens implanted in the eye used to treat cataracts or myopia. The most common type of IOL is the pseudophakic IOL. These are implanted during cataract surgery, after the cloudy crystalline lens (otherwise known as a cataract) has been removed. The pseudophakic IOL replaces the original crystalline lens, and provides the light focusing function originally undertaken by the crystalline lens. The second type of IOL, more commonly known as a phakic intraocular lens (PIOL), is a lens which is placed over the existing natural lens, and is used in refractive surgery to change the eye's optical power as a treatment for myopia, or nearsightedness. IOL usually consist of a small plastic lens with plastic side struts, called haptics, to hold the lens in place within the capsular bag inside the eye. IOL were conventionally made of an inflexible material (PMMA), although this has largely been superseded by the use of flexible materials. Most IOL fitted today are fixed monofocal lenses matched to distance vision. However, other types are available, such as multifocal IOL which provide the patient with multiple-focused vision at far and reading distance, and adaptive IOL which provide the patient with limited visual accommodation.
Published Date: 2024-04-16
Pages: 163
USD 5900.00
(Single User License)
Intraocular lens (IOL) is a lens implanted in the eye used to treat cataracts or myopia. The most common type of IOL is the pseudophakic IOL. These are implanted during cataract surgery, after the cloudy crystalline lens (otherwise known as a cataract) has been removed. The pseudophakic IOL replaces the original crystalline lens, and provides the light focusing function originally undertaken by the crystalline lens. The second type of IOL, more commonly known as a phakic intraocular lens (PIOL), is a lens which is placed over the existing natural lens, and is used in refractive surgery to change the eye's optical power as a treatment for myopia, or nearsightedness. IOL usually consist of a small plastic lens with plastic side struts, called haptics, to hold the lens in place within the capsular bag inside the eye. IOL were conventionally made of an inflexible material (PMMA), although this has largely been superseded by the use of flexible materials. Most IOL fitted today are fixed monofocal lenses matched to distance vision. However, other types are available, such as multifocal IOL which provide the patient with multiple-focused vision at far and reading distance, and adaptive IOL which provide the patient with limited visual accommodation.
Published Date: 2024-04-07
Pages: 113
USD 4900.00
(Single User License)
The global Intraocular Lens (IOLs) market size was US$ million in 2025 and is forecast to reach a readjusted size of US$ million by 2032 with a CAGR of %during the forecast period 2026-2032.
Published: 2026-01-04
Pages: 107
The global Intraocular Lens (IOLs) market was valued at US$ million in 2025 and is anticipated to reach US$ million by 2032, at a CAGR of %from 2026 to 2032.
Published: 2026-01-04
Pages: 137
The global market for Intraocular Lens (IOLs) was estimated to be worth US$ million in 2025 and is projected to reach US$ million, growing at a CAGR of %from 2026 to 2032.
Published: 2026-01-04
Pages: 143
In 2024, the global market size of Intraocular Lens (IOLs) was estimated to be worth US$ million and is forecast to reach approximately US$ million by 2031 with a CAGR of %during the forecast period 2025-2031.
Published: 2025-03-28
Pages: 177
The global Intraocular Lens (IOLs) market size was US$ million in 2024 and is forecast to a readjusted size of US$ million by 2031 with a CAGR of %during the forecast period 2025-2031.
Published: 2025-03-19
Pages: 110
The global market for Intraocular Lens (IOLs) was estimated to be worth US$ million in 2024 and is forecast to a readjusted size of US$ million by 2031 with a CAGR of %during the forecast period 2025-2031.
Published: 2025-01-16
Pages: 146
The global market for Intraocular Lens (IOLs) was valued at US$ million in the year 2024 and is projected to reach a revised size of US$ million by 2031, growing at a CAGR of %during the forecast period.
Published: 2025-01-16
Pages: 99
Intraocular lens (IOL) is a lens implanted in the eye used to treat cataracts or myopia. The most common type of IOL is the pseudophakic IOL. These are implanted during cataract surgery, after the cloudy crystalline lens (otherwise known as a cataract) has been removed. The pseudophakic IOL replaces the original crystalline lens, and provides the light focusing function originally undertaken by the crystalline lens. The second type of IOL, more commonly known as a phakic intraocular lens (PIOL), is a lens which is placed over the existing natural lens, and is used in refractive surgery to change the eye's optical power as a treatment for myopia, or nearsightedness. IOL usually consist of a small plastic lens with plastic side struts, called haptics, to hold the lens in place within the capsular bag inside the eye. IOL were conventionally made of an inflexible material (PMMA), although this has largely been superseded by the use of flexible materials. Most IOL fitted today are fixed monofocal lenses matched to distance vision. However, other types are available, such as multifocal IOL which provide the patient with multiple-focused vision at far and reading distance, and adaptive IOL which provide the patient with limited visual accommodation.
Published: 2024-04-17
Pages: 185
Intraocular lens (IOL) is a lens implanted in the eye used to treat cataracts or myopia. The most common type of IOL is the pseudophakic IOL. These are implanted during cataract surgery, after the cloudy crystalline lens (otherwise known as a cataract) has been removed. The pseudophakic IOL replaces the original crystalline lens, and provides the light focusing function originally undertaken by the crystalline lens. The second type of IOL, more commonly known as a phakic intraocular lens (PIOL), is a lens which is placed over the existing natural lens, and is used in refractive surgery to change the eye's optical power as a treatment for myopia, or nearsightedness. IOL usually consist of a small plastic lens with plastic side struts, called haptics, to hold the lens in place within the capsular bag inside the eye. IOL were conventionally made of an inflexible material (PMMA), although this has largely been superseded by the use of flexible materials. Most IOL fitted today are fixed monofocal lenses matched to distance vision. However, other types are available, such as multifocal IOL which provide the patient with multiple-focused vision at far and reading distance, and adaptive IOL which provide the patient with limited visual accommodation.
Published: 2024-04-16
Pages: 163
Intraocular lens (IOL) is a lens implanted in the eye used to treat cataracts or myopia. The most common type of IOL is the pseudophakic IOL. These are implanted during cataract surgery, after the cloudy crystalline lens (otherwise known as a cataract) has been removed. The pseudophakic IOL replaces the original crystalline lens, and provides the light focusing function originally undertaken by the crystalline lens. The second type of IOL, more commonly known as a phakic intraocular lens (PIOL), is a lens which is placed over the existing natural lens, and is used in refractive surgery to change the eye's optical power as a treatment for myopia, or nearsightedness. IOL usually consist of a small plastic lens with plastic side struts, called haptics, to hold the lens in place within the capsular bag inside the eye. IOL were conventionally made of an inflexible material (PMMA), although this has largely been superseded by the use of flexible materials. Most IOL fitted today are fixed monofocal lenses matched to distance vision. However, other types are available, such as multifocal IOL which provide the patient with multiple-focused vision at far and reading distance, and adaptive IOL which provide the patient with limited visual accommodation.
Published: 2024-04-07
Pages: 113
REPORT COVERAGE
DESCRIPTION
OVERVIEW
MARKET SEGMENTATION
CHAPTER OUTLINE
WHY THIS REPORT
QYRESEARCH'S STRENGTHS
TABLE OF CONTENTS
TABLE OF FIGURES
RLEATED REPORTS
INTEREST IN THIS REPORT?
Get A Free Sample
Request For Quotation
OR
NEED A CUSTOMIZED REPORT?
Customized Report
Request Sample
Pre-Order Enquiry
Add to Cart
Buy Now